Tags: spms + clinical trial.with.MS

Sort by: Date / Title / URL

1. BioMS shares drop 90 percent on disappointing MS result
   Shares of BioMS Medical Corp (MS.TO: Quote) plunged 90 percent on Tuesday after the company and Eli Lilly and Co (LLY.N: Quote) said their multiple sclerosis treatment failed to delay the progression of the disease in a late-stage trial.
   29-07-2009 to canada, clinical trial, ms, multiple sclerosis, research, spms by admin
2. Rebif - multiple sclerosis encyclopaedia
   Here is a table of clinical trials of Rebif.
   13-07-2007 to clinical trial, drug company, drugs, rebif, relapsing remitting, spms by admin
3. BioMS Medical initiates enrollment in pivotal U.S. phase III multiple sclerosis trial
   the first patients have been enrolled in MAESTRO-03, its U.S. pivotal phase III clinical trial of MBP8298, a proprietary synthetic peptide for the treatment of multiple sclerosis
   07-06-2007 to clinical trial, drug company, drugs, mbp8298, ms, multiple sclerosis, spms by admin
4. BioMS - Clinical Trial Information for MBP8298
   A double-blind, placebo controlled multicentre study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis
   14-08-2006 to clinical trial, drug company, drugs, mbp8298, multiple sclerosis, spms by admin
5. BioMS Medical Announces Second Quarter 2006 Results
   More than 300 patients enrolled in pivotal phase II/III multiple sclerosis trial
   14-08-2006 to canada, clinical trial, drug company, drugs, multiple sclerosis, spms by admin
6. Cambridge Antibody - ABT-874
   ABT-874 is a human anti-IL-12 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases.
   30-07-2006 to abt-874, clinical trial, drug company, drugs, multiple sclerosis, relapsing remitting, rrms, spms, treatment by admin

First / Previous / Next / Last / Page 1 of 1